扩张性心肌病的病因学确定 - - "心肌病血液面板"能改善临床评估吗?
Robin Ap Weir1, Claire Millarvie1, Catherine Smith1
1NHS Lanarkshire, University Hospital Hairmyres, Glasgow, Scotland.
Acta cardiologica
|December 8, 2025
概括
血液面板有助于确定心力衰竭患者扩张性心肌病 (DCM) 的原因. 然而,许多DCM病例即使经过广泛的测试,仍然是异常病.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 扩张性心肌病 (DCM) 可能源于各种疾病.
- 对DCM的病因调查在临床医生之间有所不同,并且往往不完整.
- 评估标准化血液面板对识别DCM原因的有用性至关重要.
研究的目的:
- 评估预先规定的血液小组在诊断扩张性心肌病 (DCM) 的潜在原因方面的有效性.
- 为了确定非缺血性DCM和心力衰竭减少射出分数 (HFrEF) 的患者综合血液检测的诊断产量.
主要方法:
- 来自区域心力衰竭诊所的55名非缺血性DCM和HFrEF患者的队列被确定.
- 患者接受了临床评估和针对潜在DCM病因的特定血液小组.
- 病因被记录在临床后评估和经过血液小组审查后修订.
主要成果:
- 在55名患者中,52.7%的DCM病例在临床评估后最初被归类为异常病.
- 最常见的特定原因是毒素 (14.5%),遗传 (12.7%) 和炎症 (10.9%).
- 血液面板导致了5.4%的患者病因的重新分类,并确定了3.6%的无关疾病.
结论:
- 扩展性心肌病 (DCM) 经常仍然是异常性,即使经过彻底的临床评估.
- 一个广泛的血液小组可以在有限数量的DCM病例中确定特定的病因.
- 可能需要进一步的研究来优化DCM的病因诊断.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Myocarditis II: Clinical Features and Diagnostic Tests
239
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
239
Dysrhythmias V: Evaluating Dysrhythmias
312
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
312
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479


